Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - Acta …, 2020 - Taylor & Francis
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …
被引用次数：22 相关文章
[PDF] researchgate.net

[PDF][PDF] Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - researchgate.net
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …

IMPROVEMENT OF FUNCTIONAL CAPACITY IN SACUBITRIL-VALSARTAN TREATED PATIENTS ASSESSED BY CARDIOPULMONARY EXERCISE TEST

G Malfatto, A Villani, S Ravaro, M Tomaselli… - Journal of …, 2019 - journals.lww.com
IMPROVEMENT OF FUNCTIONAL CAPACITY IN SACUBITRIL-VALSARTAN T... : Journal of
Hypertension IMPROVEMENT OF FUNCTIONAL CAPACITY IN SACUBITRIL-VALSARTAN …

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - ACTA …, 2020 - aisberg.unibg.it
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - Acta …, 2020 - ingentaconnect.com
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …
[PDF] academia.edu

[PDF][PDF] Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - academia.edu
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita… - Acta …, 2020 - pubmed.ncbi.nlm.nih.gov
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - ACTA …, 2020 - boa.unimib.it
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test.

G Malfatto, S Ravaro, S Caravita, C Baratto… - Acta …, 2019 - europepmc.org
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …
[PDF] academia.edu

[PDF][PDF] Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

G Malfatto, S Ravaro, S Caravita, C Baratto… - academia.edu
Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, ie ARNI) is
recommended in heart failure guidelines for patients in NYHA class II-III with reduced left …